Boston Common Asset Management LLC Has $25.30 Million Stock Position in AstraZeneca PLC $AZNCF

Boston Common Asset Management LLC reduced its holdings in shares of AstraZeneca PLC (OTCMKTS:AZNCF) by 1.9% in the second quarter, Holdings Channel reports. The institutional investor owned 182,435 shares of the company’s stock after selling 3,495 shares during the period. Boston Common Asset Management LLC’s holdings in AstraZeneca were worth $25,300,000 as of its most recent SEC filing.

AstraZeneca Trading Up 3.5%

Shares of OTCMKTS AZNCF opened at $170.51 on Friday. The company has a 50-day moving average price of $155.55 and a 200-day moving average price of $146.04. AstraZeneca PLC has a 1 year low of $120.64 and a 1 year high of $170.51.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.